MR-100A-01

· Mylan Technologies Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR-100A-01, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles [Phase 3]